Two selected commercially based nucleic acid amlification tests for the diagnosis of tuberculosis;Zastosowanie wybranych komercyjnych testów molekularnych w mikrobiologicznej diagnostyce gruźlicy

Pneumonologia i Alergologia Polska

Volumn 80, Issue 1, 2012, Pages 6-12

  Safianowska, Aleksandra ^a   Walkiewicz, Renata ^a   Nejman Gryz, Patrycja ^a   Grubek Jaworska, Hanna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Nuclear acid amplification; Tests real time PCR; Tuberculosis

Indexed keywords

BACTERIAL DNA;

ARTICLE; COMPARATIVE STUDY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

DNA, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84855182078     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Carpenter E., Drouillard B., Dailloux M. i wsp. Diagnosis of tuberculosis by AMPLICOR Mycobacterium tuberculosis test: a multicenter study. J. Clin. Microbiol. 1995; 33: 3106-3110.
2. Blakemore R., Story E., Helb D. i wsp. Evaluation of the analyti-cal performance of the Xpert MTB/RIF Assay. J. Clin. Microbiol. 2010; 48: 2495-2501.
3. van Soolingen D., Hoogenboezem T., de Haas P.E.W. i wsp. A novel pathogenic taxon of the Mycobacterium tuberculosis complex canetti: characterization of an exceptional isolate from Africa. Int. J. Syst. Bacteriol. 1997; 47: 1236-1245.
4. Cousins D.V., Bastida R., Cataldi A. i wsp. Tuberculosis in seals caused by a novel member of the Mycobacterium tuberculosis complex: Mycobacterium pinnipedii sp. nov. Int. J. Syst. Bacteriol. 2003; 53: 1305-1314.
5. Hunt J.M., Roberts G.D., Stockman I., Felmlee T.A. Detection of a genetic locus encoding resistance to rifampin in mycobacteri-al cultures and in clinical specimens. Diagn. Microbiol. Infect. Dis. 1994; 18: 219-227.
6. Hanna B.A. Diagnosis of Tuberculosis by Microbiologic Tech-niques. W: Rom W.N., Garay S. (red.). Tuberculosis. Little, Brown and Company, Boston, New York, Toronto, London 1996; 149-159.
7. Standarized Method for HPLC Identification of Mycobacteria. U.S. Departament of Heath and Human Services, CDC 1996. http://www.cdc.gov/ncidod/publications/hplc.pdf; 14.07.2011.
8. Safianowska A., Walkiewicz R., Grubek-Jaworska H. i wsp. My-colic acids analysis from various species mycobacterium by high pressure liquid chromatography (HPLC) Pneumonol. Alergol. Pol. 2002; 70: 130-138.
9. Walkiewicz R., Safianowska A., Grubek-Jaworska H. i wsp. Zas-tosowanie analizy kwasów mikolowych w diagnostyce gruźlicy i mikobakterioz - 3 lata doświadczeń. Pneumonol. Alergol. Pol. 2002; 70: 444-449.
10. Safianowska A., Walkiewicz R., Nejman-Gryz P. i wsp. Porów-nanie dwóch technik typowania pra{ogonek}tków niegruźliczych: cieczowej chromatografii wysokociśnieniowej i molekularnego systemu GenoType Mycobacterium CM/AS. Pneumonol. Alergol. Pol. 2010; 78: 363-368.
11. Centers for Disease Control and Prevention: Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis. MMWR 2009; 58: 7-10. http://www.cdc.gov//mmwr/preview/mmwrhtml/mm5801a3.htm; 14.07.2011.
12. Greco S., Girardi E., Navarra A., Saltini C. Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax 2006; 61: 783-790.
13. Boehme C.C., Nabeta P., Hillemann D. i wsp. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. N. Engl. J. Med. 2010; 363: 1005-1015.
14. Strategic and Technical Advisory Group for Tuberculosis: Re-port of the Tenth Meeting, 27-29 September 2010, WHO headquarters, Geneva, Switzerland. http://www.who.int/tb//advisory_bodies/stag_tb_report_2010.pdf; 14.07.2011.
15. Helb D., Jones M., Story E. i wsp. Rapid detection of Mycobacte-rium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin. Microbiol. 2010; 48: 229-237.
16. Cavusoglu C., Hilmioglu S., Guneri S., Bilgic A. Charachteriza-tion of rpoB mutations in rifampin-resistant clinical isolate from Turkey by DNA sequencing and line probe assay. J. Clin. Microbiol. 2002; 40: 4435-4438.
17. Ramaswamy S.V., Musser J.M. Molecular genetic basis of anti-microbial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis. 1998; 79: 3-29.
18. Prammananan T., Cheunoy W., Taechamahapun D. i wsp. Dis-tribution of rpoB mutations among multidrug-resistant Mycobacterium tuberculosis (MDRTB) strains from Thailand and development of a rapid method for mutation detection. Clin. Microbiol. Infect. 2008; 14: 446-453.
19. Gillespie S.H. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob. Agents Chemother. 2002; 46: 267-274.
20. Traore H., Fissette K., Bastian I. i wsp. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int. Tuberc. Lung Dis. 2000; 4: 481-484.
21. Augustynowicz-Kopeć E. Gruźlica lekooporna w Polsce. Anali-za epidemiologiczna, mikrobiologiczna i genetyczna. Rozprawa habilitacyjna, AM w Warszawie, Warszawa 2007.